Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

Anita Chudecka-GłazAneta Cymbaluk-PłoskaMałgorzata WężowskaJanusz Menkiszak

Published in: PloS one (2018)

The significant effect of the normalization of the HE4 marker after therapy and 50% reduction of HE4 levels before interval cytoreductive surgery on PFS and OS confirmed that HE4 might be an independent prognostic factor of treatment response. HE4 measurements performed during first-line treatment of ovarian cancer may have prognostic significance.

Keyphrases

prognostic factors
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
minimally invasive
peritoneal dialysis
coronary artery bypass
patient reported outcomes
mesenchymal stem cells
atrial fibrillation
radiation therapy
patient reported
metastatic renal cell carcinoma